Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ramin Samadani
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity With the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Structural Modifications of (Z)-3-(2-Aminoethyl)-5-(4-Ethoxybenzylidene)thiazolidine-2,4-Dione That Improve Selectivity for Inhibiting the Proliferation of Melanoma Cells Containing Active ERK Signaling
Organic and Biomolecular Chemistry
Organic Chemistry
Theoretical Chemistry
Biochemistry
Physical